BioSpace News Archive

Orthodontic elastics are disposable elastic ligatures used in orthodontic treatment to close the gap between teeth, and adjust bite and jaw position.

The increasing number of cases related to cardiovascular diseases and diabetes across a large chunk of the global populace will help in increasing the growth rate of the fractional flow reserve devices market during the forecast period of 2020-2030.

Obstetrics and gynecology are medical specialties functioning together or separately to ensure complete health care of women.

The popularity of antimicrobial susceptibility testing technologies has stemmed from the prevalence of infectious diseases that are of bacterial origin.

The global celiac disease market is prophesied to rake in a heavy demand on account of three decisive factors such as healthy government initiatives, prevalence of the disease, and increased consumption of foods containing gluten.

Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides.

QIAGEN is responsible for product development and manufacturing, while DiaSorin is responsible for global commercialization of the new solution

Core One Labs Inc. is pleased to announce its wholly owned subsidiary Vocan Biotechnologies Inc. has initiated the engineering and design of a proprietary enzymatic production system for the manufacturing of API-grade N,N-dimethyltryptamine.

Immunovia will publish the company’s interim report for the period January 1 - March 31, 2021 on Wednesday, April 28, 2021 at 16:00 CET.

Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, announced that the U.S. Food and Drug Administration has approved its Investigational Device Exemption application to conduct a U.S. trial for the Contour Neurovascular System™, indicated for the treatment of intracranial aneurysms.